GrantExec

Grants for Special district governments - Health

Explore 2,006 grant opportunities

Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)
$250,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Not specified

Date Added

Dec 16, 2024

This funding opportunity supports research institutions and organizations in developing standardized practices for handling biospecimens to improve the reliability of clinical biomarker assays used in cancer diagnosis and treatment.

Education
State governments
Model Continuums of Care Initiative (MCCI) to Advance Health Equity and End Health Disparities Among Women and Girls in Racial/Ethnic Minority and Other Underserved Communities (U34 Clinical Trials Required)
$225,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Feb 19, 2025

Date Added

Dec 16, 2024

This funding opportunity provides financial support for organizations to develop and implement strategies that improve health equity and reduce health disparities among underserved women and girls, particularly those from racial and ethnic minority backgrounds.

Education
State governments
Connecting Kids to Coverage Outreach and Enrollment Cooperative Agreements (CKC) 2025
$3,000,000
U.S. Department of Health & Human Services (Centers for Medicare ; Medicaid Services)
Federal

Application Deadline

Mar 7, 2025

Date Added

Dec 13, 2024

This grant provides funding to state and local governments, nonprofits, and educational institutions to help enroll eligible children in Medicaid and CHIP while improving their retention in these programs.

Health
State governments
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)
$275,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Not specified

Date Added

Dec 12, 2024

This funding opportunity supports innovative early-stage bioengineering research projects that develop new tools and technologies to improve biomedical research and healthcare delivery.

Education
State governments
HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed)
$100,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Not specified

Date Added

Dec 12, 2024

This funding opportunity supports researchers in identifying and studying underexplored proteins related to pain, aiming to develop new treatments and improve pain management strategies.

Education
State governments
High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Not specified

Date Added

Dec 12, 2024

This grant provides funding for innovative, interdisciplinary research projects that aim to advance understanding and treatment of diseases related to diabetes, digestive disorders, liver diseases, metabolic and nutritional disorders, kidney and urologic diseases, and obesity.

Food and Nutrition
State governments
Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Optional)
$500,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Feb 28, 2025

Date Added

Dec 12, 2024

This funding opportunity supports innovative research projects that address social factors affecting health to reduce disparities and promote health equity among underserved populations in the U.S.

Education
State governments
Broad Spectrum Products Against Multiple Neurotoxin Botulinum Serotypes (R61/R33 Clinical Trial Not Allowed)
$300,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

May 2, 2025

Date Added

Dec 12, 2024

This funding opportunity supports the development of innovative therapies to counteract the effects of Botulinum Neurotoxin, targeting researchers and organizations focused on advancing treatments for this serious health threat.

Health
State governments
Deriving Common Data Elements from Real-World Data for Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (U24 Clinical Trial Not Allowed)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Feb 28, 2025

Date Added

Dec 12, 2024

This funding opportunity supports the development of standardized data elements for Alzheimer’s Disease and related dementias research, inviting applications from universities, nonprofits, and other organizations to enhance data sharing and collaboration in the field.

Health
State governments
Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed)
$275,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Jun 18, 2026

Date Added

Dec 11, 2024

This funding opportunity supports U.S.-based organizations in developing innovative technologies that can improve the efficiency of therapeutic development and translational research across multiple diseases.

Health
State governments
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
$200,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Oct 16, 2025

Date Added

Dec 11, 2024

This funding opportunity supports innovative early-stage bioengineering research projects aimed at improving cancer research, care delivery, and healthcare accessibility, encouraging collaboration between biomedical researchers and engineers.

Education
State governments
Complement-ARIE New Approach Methodologies (NAMs) Technology Development Centers (UM1 Clinical Trial Optional)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Mar 18, 2025

Date Added

Dec 11, 2024

This funding opportunity supports U.S.-based institutions and organizations in developing innovative human-based research models to improve understanding of health and disease, with a focus on inclusivity and collaboration.

Health
State governments
Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (U01 Clinical Trial Optional)
Contact for amount
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Feb 21, 2025

Date Added

Dec 11, 2024

This funding opportunity supports research teams from various sectors to explore how sex differences influence the biological factors related to Alzheimer’s disease and its treatment, aiming to enhance understanding and improve precision medicine approaches.

Health
State governments
Role of Defective Proviruses in HIV Persistence (R01 Clinical Trial Not Allowed)
$500,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Jan 7, 2026

Date Added

Dec 10, 2024

This funding opportunity supports researchers investigating how defective HIV proviruses contribute to the persistence of the virus in individuals on antiretroviral therapy, with a focus on improving understanding and treatment strategies for HIV.

Health
State governments
Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed) 2025
$250,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Dec 5, 2025

Date Added

Dec 10, 2024

This funding opportunity supports innovative, time-sensitive research projects that enhance ongoing clinical studies related to arthritis, musculoskeletal, and skin diseases by leveraging existing patient data and samples.

Health
Public and State controlled institutions of higher education
K01 Mentored Research Scientist Development Award
$100,000
U.S. Department of Health & Human Services (Centers for Disease Control and Prevention - ERA)
Federal

Application Deadline

Not specified

Date Added

Dec 10, 2024

This funding opportunity supports early-career scientists in the U.S. who are focused on conducting impactful research to improve worker health and safety in various industries.

Health
State governments
Occupational Safety and Health Research (R01)
$400,000
U.S. Department of Health & Human Services (Centers for Disease Control and Prevention - ERA)
Federal

Application Deadline

Not specified

Date Added

Dec 10, 2024

This funding opportunity supports research projects that aim to improve workplace safety and health by identifying and addressing occupational hazards, ultimately reducing injuries and illnesses among workers.

Health
State governments
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
$300,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Not specified

Date Added

Dec 10, 2024

This funding opportunity provides financial support for short-term clinical trials aimed at improving treatments for arthritis, musculoskeletal, and skin diseases, targeting researchers and institutions focused on innovative healthcare solutions.

Health
State governments
NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
$250,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Not specified

Date Added

Dec 10, 2024

This funding opportunity supports researchers at U.S. institutions in conducting clinical trials focused on improving treatments for arthritis, musculoskeletal, and skin diseases.

Health
State governments
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
$250,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Not specified

Date Added

Dec 10, 2024

This funding opportunity supports researchers conducting observational studies to improve understanding and treatment of musculoskeletal, rheumatic, and skin diseases, ultimately informing future clinical trials.

Health
State governments